Skip to main content

Table 2 Univariate analysis of factors associated with overall survival of 187 patients with UCB

From: PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway

Variable All cases RR (95% CI) P valuea  
Age(years)    0.309  
≤60b 80 1   
>60 107 1.332 (0.767-2.315)   
Gender    0.648  
Male 166 1   
Female 21 0.807 (0.321-2.026)   
Tumor multiplicity    0.676  
Unifocal 79 1   
Multifocal 108 1.443 (0.852-2.471)   
WHO grade    0.022  
G1 46 1   
G2 66 2.304 (0.968-5.485)   
G3 75 3.206 (1.396-7.363)   
pT status    <0.001  
pT1 35 1   
pT2 95 1.535 (0.890-2.653)   
pT3 37 3.025 (1.242-7.363)   
pT4 20 7.457 (2.950-18.847)   
pN status    <0.001  
pN- 157 1   
pN+ 30 8.904 (5.056-15.681)   
PinX1    <0.001  
Negative expression 83 5.148 (2.708-9.786)   
Positive expression 104 1   
  1. aChi-square test. bmean age. RR: relative risk. CI: confidence interval.
  2. UCB: urothelial carcinoma of bladder.